Tag: biotech

0 0 0 Comment
Posted in HEADLINES

Edesa Biotech shares jump 14% premarket after early review of COVID treatment finds it should continue trial

Edesa Biotech Inc. shares EDSA, -2.11% jumped 14% premarket on Friday, after the Canadian biotech, which is listed on Nasdaq,…

0 0 0 Comment
Posted in HEADLINES

Biotech Century Therapeutics to offer 10.6 million shares in IPO, priced at $18 to $20 each

Biotech Century Therapeutics Inc. IPSC, set terms for its initial public offering on Monday, with plans to offer 10.6 million…

0 0 0 Comment
Posted in HEADLINES

Janux Therapeutics set to go public after upsized IPO prices, valuing the biotech at $646 million

Janux Therapeutics Inc.’s stock is set to start trading Friday, after the California-based biotechnology company developing cancer treatments’ upsized initial…

0 0 0 Comment
Posted in HEADLINES

Novavax CFO to step down, biotech company says

Novavax Inc. NVAX, +10.82% said late Tuesday that Chief Financial Officer Greg Covino is stepping down for personal reasons, but…

0 0 0 Comment
Posted in HEADLINES

FibroGen stock drops as biotech clarifies data classification in study data

FibroGen Inc. FGEN, -2.78% shares fell in the extended session Tuesday after the biotech drug maker said an analysis of…

0 0 0 Comment
Posted in HEADLINES

Illumina stock rallies 13% after biotech says it expects Q1 sales to top $1 billion

Shares of Illumina Inc. ILMN, -0.13% jumped more than 13% in the extended session Monday after the biotech company said…

0 0 0 Comment
Posted in HEADLINES

Biotech Certara files for IPO

Biotech company Certara Inc. has filed for an initial public offering, according to a filing late Wednesday. The Princeton, N.J.,…

0 0 0 Comment
Posted in HEADLINES

Biotech ETFs at two-week highs on upbeat vaccine news

Biotech exchange-traded funds got a bounce Friday from bullish news on coronavirus treatments. The ALPS Medical Breakthroughs ETF SBIO, +0.65%,…

Gavel
0 85 0 Comment
Posted in FINANCE Stock Market

Swedish kidney disease biotech Calliditas Therapeutics files for a $75 million US IPO

Calliditas Therapeutics, a Swedish biotech developing novel therapies for inflammatory kidney disease, filed on Thursday with the SEC to raise…